Particle size distribution of viable nebulized bacteriophage for the treatment of multi-drug resistant Pseudomonas aeruginosa

Affiliations

• ¹ Yale School of Medicine, New Haven, CT, United States.
• ² College of Wooster, Wooster, OH, United States.
• ³ Department of Biomedical Sciences, Frank Netter School of Medicine, Quinnipiac University, North Haven, CT, United States.
• ⁴ Department of Pediatrics, Yale School of Medicine, New Haven, CT, United States.
• ⁵ Program in Microbiology, Yale School of Medicine, New Haven, CT, United States; Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT, United States; Center for Phage Biology & Therapy, Yale University, New Haven, CT, United States.
• ⁶ Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT, United States; Center for Phage Biology & Therapy, Yale University, New Haven, CT, United States.
• ⁷ Center for Phage Biology & Therapy, Yale University, New Haven, CT, United States; Department of Internal Medicine Yale School of Medicine, New Haven, CT, United States.
• ⁸ Department of Pediatrics, Yale School of Medicine, New Haven, CT, United States. Electronic address: Thomas.s.murray@yale.edu.